At the phenotypic level, the overexpression of survivin has been linked to tumor progression in prostate cancer [26], enhanced migratory potential of gastric cancer cells [27], and increased survival and chemoresistance in breast cancer models [28]. Here, BIRC5 is linked to neoplasm.